Trading Places is Stockhead’s weekly recap of substantial holder movements focusing on fund managers.

Substantial shareholders are shareholders holding 5 per cent or more of a company’s shares and these can be directors, individual investors or institutional investors.

Shareholders are required to announce to the exchange when they cross above or below the 5 per cent threshold and any change in their holdings while they remain above 5 per cent.

Buyers

Among Regal Funds Management’s buys this week were Richard White-backed, know-your-customer fintech Kyckr (ASX: KYK) and recent uranium convertee Lotus Resources (ASX: LOT) — formerly known as Hylea.

It already was a substantial holder in Kyckr, taing its stake to 6.14 per cent and became one of Lotus, buying a 5 per cent stake. But it only spent $600,000 and $280,000 respectively.

Since Stavely Minerals’ (ASX: SVY) 40 per cent copper hit there has been increased interest in companies with porphyry copper-gold projects. One is Carawine Resources (ASX: CWX) and private investment company Illewa increased its holdings to 9.05 per cent.

1832 Asset Management increased its holdings in Bellevue Gold (ASX: BGL) and Exore Resources (ASX: ERX) to 12.35 per cent and 7.65 per cent respectively.

Despite months of doom and gloom about the retail sector, AustralianSuper bought into Adairs (ASX: ADH), taking a 5.02 per cent.

As Athena Resources (ASX: AHN) seeks to re-enter the ASX, three substantial holders entered its list, one of which was Airlie Funds Management which took a 5.08 per cent stake.

IOOF bought a 5.37 per cent stake in RhinoMed (ASX: RNO) and increased its holdings in MetalsX (ASX: MLX) to 6.67 per cent.

New York based fund manager Emprey Asset Management bought a 8.94 per cent stake in Benetic Biopharma (ASX: BLT).

Company Code Market Cap Holder Stake Status
Lotus Resources LOT $13.9M Copia Investment Partners 5.37% Becoming
Paringa Resources PNL $34.4M AustralianSuper 13.40% Increasing
Adairs ADH $311.8M AustralianSuper 5.02% Becoming
Titanium Sands TSL $10.5M Robert Nelson 9.99% Becoming
Pacific Current Group PAC $328.7M Fidelity 6.19% Increasing
Benetic Biopharma BLT $17.5M Sabby Management 8.94% Becoming
Blackham Resources BLK $44.1M Delphi 10.06% Increasing
Athena Resources AHN Suspended Goldway Mega Trade 7.40% Becoming
Athena Resources AHN Suspended Stonydeep Investments 6.28% Becoming
Mineral Resources AHN Suspended Airlie Funds Management 5.08% Becoming
Kyckr KYK $42.4M Regal Funds Management 6.15% Increasing
Eclipx Group ECX $548.8M Maso Capital Investments 5.78% Becoming
MetalsX MLX $149.3M IOOF 6.67% Increasing
Babylon Pump and Power BPP $10.5M G & N Lord Superannuation 17.25% Increasing
Carawine Resources CWX $14.7M Illwea 9.05% Increasing
Bigtincan BTH $160.6M Regal Funds Management 17.05% Increasing
Getswift GSW $124.4M Charles Frischer 8.10% Increasing
Bellevue Gold BGL $336.1M 1832 Asset Management 12.35% Increasing
Exore Resources ERX $44.5M 1832 Asset Management 7.65% Increasing
Benetic Biopharma BLT $17.5M Empery Asset Management 8.94% Becoming
Rhinomed RNO $40.6M IOOF 5.37% Becoming
Prime Financial Group PFG $15.3M KIUT Investments 5.88% Becoming
Marindi Metals MZN $6.0M Thomas Henderson 6.36% Becoming
The Agency Group AU1 $8.0M Benjamin Collier 9.12% Increasing
MRG Metals MRQ $6.8M Christopher Gregory 5.67% Becoming
Shriro Holdings SHM $67.0M Australian Ethical Investment 9.88% Increasing
Lotus Resources LOT $13.9M Regal Funds Management 5.11% Becoming
Food Revolution Group FOD $47.8M Fanucci and Domenal Enterprises 8.95% Increasing
Rafaella Resources RFR $7.9M Adam Blumenthal 16.64% Increasing
The Agency Group AU1 $8.0M Matt Lahood 8.32% Increasing

Sellers

BVF Partners completely sold out of Opthea (ASX: OPT), parting with the last $20 million in stock. It owned up to 15 per cent of the company earlier this year but has been gradually selling.

The company nearly quadrupled in a matter of days after its main drug excelled at battling wet-AMD in its Phase-II clinical trial. But while it plans commercialisation, it is undertaking further trials and still waiting on the complete set of results of its successful clinical stint.

Amaysim (ASX: AYS) has more than halved in recent weeks after poor financial results and Fidelity has cut its ownership of the company to 7.5 per cent.

1832 Asset Management has done likewise with Africa-focused gold miner Cardinal Resources (ASX: CDV).

It’s been seven weeks since Roots Sustainable Agricultural Technologies (ASX: ROO) announced it was getting into the plant-based meat craze. While it initially surged, it has since retreated its pre-August levels. Private investor James Schwarz, through his company Jamber Investments, has cut his stake to only 3.2 per cent.

Company Code Market Cap Holder Current Stake Status
Bigtincan BTH $148.0M Australian Ethical Investment 12.00% Decreasing
Frontier Digital Ventures FDC $176.8M Fidelity 4.97% Ceasing
Cardinal Resources CDV $172.4M 1832 Asset Management 7.55% Decreasing
Voltage IP VIP Suspended Wee Min Chen 7.78% Decreasing
iCar Asia ICQ $108.2M PM Capital Group 9.64% Decreasing
Pacific Smiles Group PSQ $235.6M Alexander Abrahams 22.26% Decreasing
Flexigroup FXL $938.7M Renaissance Smaller Companies 4.97% Ceasing
Audinate Group AD8 $513.3M Smallco Investment Manager 8.12% Decreasing
Apiam Animal Health AHX $53.7M Regal Funds Management 13.04% Decreasing
Emeco Holdings EHL $594.7M Paradice Investment Management 5.17% Decreasing
Opthea OPT $853.5M BVF Partners 0% Ceasing
Sensera SE1 $21.6M Dead Knick Capital 0.14% Ceasing
LiveTiles LVT $281.2M Regal Funds Management 4.99% Ceasing
Amaysim AYS $100.3M Fidelity 7.50% Decreasing
Roots Sustainable Agricultural Technologies ROO $4.7M Jamber Investments 3.21% Ceasing